Literature DB >> 11818396

Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity.

Xiaolin Gu1, Sara Samuel, Mohamed El-Shabrawey, Ruth B Caldwell, Manuela Bartoli, Dennis M Marcus, Steven E Brooks.   

Abstract

PURPOSE: To investigate the effects of prolonged hyperoxia on vascular recovery and glia survival after experimentally induced retinopathy of prematurity (ROP) in the mouse.
METHODS: The effects of hyperoxia on revascularization and vitreous neovascularization were compared between mice raised in 75% oxygen from postnatal day (P)7 to P12, followed by room air recovery and mice raised in 75% oxygen from P7 to P27. The status of astrocytes and Müller cells was evaluated by glial fibrillary acidic protein (GFAP) immunohistochemistry on retinal wholemounts and serial sections. A window of susceptibility to oxygen-induced vaso-obliteration was defined by comparing the extent of retinal vaso-obliteration resulting from 2 days of hyperoxia beginning on P7, P9, P11, P13, or P15.
RESULTS: Oxygen-induced vaso-obliteration of retinal capillaries was limited to the period between birth and P15. Paradoxically, revascularization was markedly accelerated and neovascularization markedly reduced in mice maintained in prolonged hyperoxia (P7-P27) compared with mice recovering in room air. The extended use of 75% oxygen during the recovery period was associated with preservation of astrocytes and Müller cells in the avascular retina.
CONCLUSIONS: The antiangiogenic effect of hyperoxia on retinal capillaries is strongly dependent on postnatal age. A protocol of continuous 75% supplemental oxygen accelerates recovery of inner retinal vasculature and prevents vitreous neovascularization, by a mechanism that may involve preservation of inner retinal glia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11818396

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  36 in total

Review 1.  The mouse retina as an angiogenesis model.

Authors:  Andreas Stahl; Kip M Connor; Przemyslaw Sapieha; Jing Chen; Roberta J Dennison; Nathan M Krah; Molly R Seaward; Keirnan L Willett; Christopher M Aderman; Karen I Guerin; Jing Hua; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06       Impact factor: 4.799

Review 2.  Arginase: an old enzyme with new tricks.

Authors:  Ruth B Caldwell; Haroldo A Toque; S Priya Narayanan; R William Caldwell
Journal:  Trends Pharmacol Sci       Date:  2015-04-27       Impact factor: 14.819

Review 3.  Animal models of ocular angiogenesis: from development to pathologies.

Authors:  Chi-Hsiu Liu; Zhongxiao Wang; Ye Sun; Jing Chen
Journal:  FASEB J       Date:  2017-07-24       Impact factor: 5.191

4.  Quantifying three-dimensional rodent retina vascular development using optical tissue clearing and light-sheet microscopy.

Authors:  Jasmine N Singh; Taylor M Nowlin; Gregory J Seedorf; Steven H Abman; Douglas P Shepherd
Journal:  J Biomed Opt       Date:  2017-07-01       Impact factor: 3.170

5.  Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy.

Authors:  Mohamed Al-Shabrawey; Manuela Bartoli; Azza B El-Remessy; Daniel H Platt; Sue Matragoon; M Ali Behzadian; Robert W Caldwell; Ruth B Caldwell
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

6.  Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model.

Authors:  Wenbo Zhang; Harumasa Yokota; Zhimin Xu; Subhadra P Narayanan; Lauren Yancey; Akitoshi Yoshida; Dennis M Marcus; Robert W Caldwell; Ruth B Caldwell; Steven E Brooks
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-08-11       Impact factor: 4.799

7.  Expression of protein kinase CK2 in astroglial cells of normal and neovascularized retina.

Authors:  Andrei A Kramerov; Mehrnoosh Saghizadeh; Hao Pan; Andrea Kabosova; Mathias Montenarh; Khalil Ahmed; John S Penn; Candy K Chan; David R Hinton; Maria B Grant; Alexander V Ljubimov
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

8.  Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model.

Authors:  Yuta Saito; Abhineet Uppal; Grace Byfield; Steven Budd; M Elizabeth Hartnett
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

9.  Transforming growth factor beta1 induction of vascular endothelial growth factor receptor 1: mechanism of pericyte-induced vascular survival in vivo.

Authors:  Shu-Ching Shih; Meihua Ju; Nan Liu; Jan-Rung Mo; Joshua J Ney; Lois E H Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-03       Impact factor: 11.205

10.  HMG-CoA reductase inhibitors (statin) prevents retinal neovascularization in a model of oxygen-induced retinopathy.

Authors:  Manuela Bartoli; Mohamed Al-Shabrawey; Mohamed Labazi; M Ali Behzadian; Mohamed Istanboli; Azza B El-Remessy; Robert W Caldwell; Dennis M Marcus; Ruth B Caldwell
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-20       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.